Fetomaternal Outcome of Pregnancy in Women with Thyroid Disease at Tertiary Care Hospital

Authors

  • Nadia Bashir Department of Obstetrics & Gynaecology, Bolan Medical College Hospital (BMCH), Quetta, Pakistan
  • Fozia Muhammad Bakhsh Department of Obstetrics & Gynaecology, Bolan Medical College Hospital (BMCH), Quetta, Pakistan
  • Saira Mastoi Department of Obstetrics & Gynaecology, Bolan Medical College Hospital (BMCH), Quetta, Pakistan
  • Nida Reki Department of Obstetrics & Gynaecology, Bolan Medical College Hospital (BMCH), Quetta, Pakistan
  • Merman Achakzai Department of Obstetrics & Gynaecology, Bolan Medical College Hospital (BMCH), Quetta, Pakistan
  • Mehwish Department of Obstetrics & Gynaecology, Bolan Medical College Hospital (BMCH), Quetta, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i7.2394

Keywords:

Thyroid disease, Pregnancy, Fetomaternal outcome, Hypothyroidism, Hyperthyroidism, Neonatal outcomes

Abstract

Background: Thyroid dysfunction is among the most common endocrine disorders in pregnancy and is associated with adverse maternal and neonatal outcomes. Objective: To determine fetomaternal outcomes of pregnancy in women with thyroid disease at a tertiary care hospital. Methodology: At the Bolan Medical College Hospital in Quetta, 250 pregnant patients with thyroid conditions aged 18 to 40 participated in a descriptive cross-sectional study. A standardized proforma was used to gather data on demographic, obstetric, and neonatal outcomes, and SPSS 26 was used for analysis. Maternal hypertension, pre-eclampsia, postpartum hemorrhage, cesarean delivery, oligohydramnios, low birth weight, and neonatal hyperbilirubinemia were among the outcomes evaluated. Thyroid illness type, parity, and maternal age were used for stratification. Results: Of the patients, 54.8% had hypothyroidism and 45.2% had hyperthyroidism. Prenatal hypertension (46%), pre-eclampsia (50%), postpartum hemorrhage (52.4%), LSCS (48.4%), oligohydramnios (46%), low birth weight (47.6%), and neonatal hyperbilirubinemia (42.4%) were among the high rates of unfavorable outcomes that were noted. Although there were indications toward a higher risk of low birth weight in older moms, stratified analysis revealed no significant correlation between age, parity, or thyroid type with major outcomes. Conclusion: Thyroid disorders during pregnancy substantially increase maternal and neonatal morbidity. Early screening, timely treatment, and close monitoring are crucial to improve outcomes.

Downloads

Download data is not yet available.

References

1. Khan I, Okosieme OE, Lazarus JH. Current challenges in the pharmacological management of thyroid dysfunction in pregnancy. Expert Rev Clin Pharmacol. 2017;10:97–109.

https://doi.org/10.1080/17512433.2017.1253471

2. Rotondi M, Chiovato L, Pacini F, Bartalena L, Vitti P. Management of subclinical hypothyroidism in pregnancy: a comment from the Italian society of endocrinology (SIE) and the Italian thyroid association (AIT) to the 2017 ATA guidelines. Thyroid. 2018;28:551–5.

https://doi.org/10.1089/thy.2017.0424

3. Delitala AP, Capobianco G, Cherchi PL, Dessole S, Delitala G. Thyroid function and thyroid disorders during pregnancy: a review and care pathway. Arch Gynecol Obstet. 2019;299:327 38.

https://doi.org/10.1007/s00404-018-5018-8

4. Zhou M, Wang M, Li J, Luo X, Lei M. Eects of thyroid diseases on pregnancy outcomes. Exp Ther Med. 2019;18(3):1807-15.

https://doi.org/10.3892/etm.2019.7739

5. Medenica S, Nedeljkovic O, Radojevic N, Stojkovic M, Trbojevic B, Pajovic B. Thyroid dysfunction and thyroid autoimmunity in euthyroid women in achieving fertility. Eur Rev Med Pharmacol Sci. 2015;19:977–87.

6. De Groot L., Abalovich M, Alexander EK, Amino N, Barbour L., Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543-65.

https://doi.org/10.1210/jc.2011-2803.

7. Karakosta P. Alegakis D, Georgiou V, Roumeliotaki T, Fthenou E, Vassilaki M, et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab. 2012;97(12):4464-72.

https://doi.org/10.1210/jc.2012-2540.

8. Galofre, J.C. and Davies, T.F. (2009) Autoimmune Thyroid Disease in Pregnancy: A Women's Health (2002), 18, 1847-1856. Review. of Journal

https://doi.org/10.1089/jwh.2008.1234.

9. Fitzpatrick, D.I... and Russell, M.A. (2010) Diagnosis and Management of Thyroid Disease in Pregnancy. Obstetrics and Gynecology Clinics of North America, 37, 173-193.

https://doi.org/10.1016/j.oge.2010.02.007.

10. Azizi, F. and Delshad, H. (2014) Thyroid Derangements in Pregnancy. Iranian Journal of Endocrinology and Metabolism, 15, 491-508.

11. Reid, S.M., Middleton, P., Cossich, M.C. and Crowther, C.A. (2010) Interventions for Clinical and Subclinical Hypothyroidism in Pregnancy. Cochrane Database of Systematic Reviews, No. 7, CD007752.

https://doi.org/10.1002/14651858.CD007752.pub2

12. Noten AM, Loomans EM, Vrijkotte TG, van de Ven PM, van Trotsenburg AS, Rotteveel J, et al. Maternal hypothyroxinaemia in early pregnancy and school performance in 5-year-old ospring. Eur J Endocrinol. 2015;173:563–71.

https://doi.org/10.1530/eje-15-0397

13. Gilbert EW, Tay CT, Hiam DS, Teede HJ, Moran LJ. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin Endocrinol. 2018;89:683–99.

https://doi.org/10.1111/cen.13828

14. Kiran Z, Sheikh A, Malik S, Meraj A, Masood M, Ismail S, et al. Maternal characteristics and outcomes aected by hypothyroidism during pregnancy (maternal hypothyroidism on pregnancy outcomes, MHPO-1). BMC Pregnancy Childbirth. 2019;19(1):476.

https://doi.org/10.1186/s12884-019-2596-9

15. Sreelatha S, Nadagoudar S, Devi AL. The study of maternal and fetal outcome in pregnant women with thyroid disorders. Int J Reprod Contracept Obstet Gynecol. 2017;6:3507-13.

https://doi.org/10.18203/2320-1770.ijrcog20173473

16. Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., et al. (2011) Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and Postpartum. Thyroid Official Journal of the American Thyroid Association, 21, 1081-1125.

https://doi.org/10.1089/thy.2011.0087

17. Chen, L.M., Du, W.J., Dai, J., Zhang, Q., Si, G.X., Yang, H., et al. (2014) Effects of Subclinical Hypothyroidism on Maternal and Perinatal Outcomes during Pregnancy: A Single-Center Cohort Study of a Chinese Population. PLOS ONE, 9,

https://doi.org/10.1371/journal.pone.0109364 109364.

18. Kiran Z, Sheikh A, Malik S, Meraj A, Masood M, Ismail S, et al. Maternal characteristics and outcomes affected by hypothyroidism during pregnancy (maternal hypothyroidism on pregnancy outcomes, MHPO-1). BMC Pregnancy Childbirth. 2019;19(1):476.

https://doi.org/10.1186/s12884-019-2596-9

19. Sreelatha S, Nadagoudar S, Devi AL. The study of maternal and fetal outcome in pregnant women with thyroid disorders. Int J Reprod Contracept Obstet Gynecol. 2017;6:3507-13.

https://doi.org/10.18203/2320-1770.ijrcog20173473

20. Puthiyachirakal, M. A., Hopkins, M., AlNatsheh, T., & Das, A. (2025). Overview of thyroid disorders in pregnancy. Maternal health, neonatology and perinatology, 11(1), 9.

https://doi.org/10.1186/s40748-025-00208-9.

21. Dilshodovna, A. M., & Singh, S. (2025). THYROID DISORDERS AND PREGNANCY. Web of Medicine: Journal of Medicine, Practice and Nursing, 3(4), 295-303.

22. Bogović Crnčić, T., Ćurko-Cofek, B., Batičić, L., Girotto, N., Tomaš, M. I., Kršek, A., Krištofić, I., Štimac, T., Perić, I., Sotošek, V., & Klobučar, S. (2024). Autoimmune Thyroid Disease and Pregnancy: The Interaction Between Genetics, Epigenetics and Environmental Factors. Journal of clinical medicine, 14(1), 190.

https://doi.org/10.3390/jcm14010190.

23. Moleti, M., Sturniolo, G., Di Mauro, M., Russo, M., & Vermiglio, F. (2018). Autoimmune thyroid diseases and pregnancy. Annals of Thyroid, 3(7).

https://doi.org/10.21037/aot.2018.07.03

24. Joshi, J. S., Shanoo, A., Patel, N., & Gupta, A. (2024). From Conception to Delivery: A Comprehensive Review of Thyroid Disorders and Their Far-Reaching Impact on Feto-Maternal Health. Cureus, 16(2), e53362.

https://doi.org/10.7759/cureus.53362.

25. Negro, R., & Mestman, J. H. (2011). Thyroid disease in pregnancy. Best Practice & Research Clinical Endocrinology & Metabolism, 25(6), 927-943.

https://doi.org/10.1016/j.beem.2011.07.010

26. Cao, H., Oghenemaro, E. F., Latypova, A., Abosaoda, M. K., Zaman, G. S., & Devi, A. (2025). Advancing clinical biochemistry: addressing gaps and driving future innovations. Frontiers in Medicine, 12, 1521126.

https://doi.org/10.3389/fmed.2025.1521126

27. Casey, B. M., & Leveno, K. J. (2006). Thyroid disease in pregnancy. Obstetrics & Gynecology, 108(5), 1283-1292.

https://doi.org/10.1097/01.aog.0000244103.91597.c5

28. No, G. T. G. (2025). Management of Thyroid Disorders in Pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology, 132, e130-e161.

https://doi.org/10.1111/1471-0528.18088

29. Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., ... & Sullivan, S. (2017). 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid, 27(3), 315-389.

https://doi.org/10.1089/thy.2016.0457

Downloads

Published

2025-07-15

How to Cite

Bashir, N., Bakhsh, F. M., Mastoi, S., Reki, N., Achakzai, M., & Mehwish. (2025). Fetomaternal Outcome of Pregnancy in Women with Thyroid Disease at Tertiary Care Hospital. Indus Journal of Bioscience Research, 3(7), 1188-1194. https://doi.org/10.70749/ijbr.v3i7.2394